Ascaris Lumbricoides Cystatin Impairs IL ‐1β Maturation and CD14 Expression in Human Monocytes
Immunology · 2025
DOI: 10.1111/imm.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Ana Lozano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunological Research, University of Cartagena, Cartagena, Colombia. Hauptthemen laut MEDLINE: Lipopolysaccharide Receptors, Interleukin-1beta, Monocytes, Cystatins. Die Arbeit nennt 72 Literaturangaben. Gefördert von: Ministerio de Ciencia, Tecnología e Innovación, Universidad de Cartagena, Sistema General de Regalías de Colombia.
Abstract (Originalsprache)
Ascaris lumbricoides cystatin (Al‐CPI), a cysteine protease inhibitor, has shown anti‐inflammatory effects in models of house dust mite‐induced respiratory allergy and experimental colitis. Since monocytes are primary targets of cystatins, and helminth‐derived products can induce immunoregulatory monocytes that mitigate autoimmune and inflammatory diseases in murine models, we aimed to investigate the immunoregulatory effects of Al‐CPI on human monocytes and its mechanisms. Monocytes were isolated from healthy donors using CD14+ magnetic beads and treated with recombinant Al‐CPI (rAl‐CPI) before activation with LPS. Surface marker expression and caspase‐1 activity were analysed by flow cytometry, while cytokine levels were quantified using bead‐based assays. Caspase‐8 inhibition was measured by fluorescence, and pro‐IL‐1β expression was evaluated by Western blot. RNA‐seq and differential gene expression analyses were performed using DESeq2 and GSEA. rAl‐CPI reduced cell surface expression of HLA‐DR and CD14 as well as IL‐1β levels in cell culture supernatants. Transcriptomic analysis identified 30 differentially expressed genes (12 upregulated and 18 downregulated; padj < 0.05 and fold change [FC] < |1.5|), including the downregulation of CD14 and SLAMF1 , both involved in LPS‐mediated signalling through the TLR4‐TRIF pathway. GSEA analysis showed that rAl‐CPI plus LPS induced an enrichment of the IFN signalling pathway compared with LPS (NES = 1.88; p adj < 0.0001). Further analysis of IL‐1β production and maturation showed that rAl‐CPI did not alter pro‐IL‐1β levels, but reduced caspase‐1 activation. In conclusion, rAl‐CPI may impair IL‐1β maturation and release by modulating the alternative inflammasome activation, potentially through downregulation of CD14 and other key regulatory molecules involved in this pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Immunological Research, University of Cartagena, Cartagena, Colombia.
- Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.
ORCID-Profile: Ana Lozano, Andrew R Williams
Förderung
- Ministerio de Ciencia, Tecnología e Innovación
- Universidad de Cartagena
- Sistema General de Regalías de Colombia
Zitieren
APA
Lozano, A., Zakzuk, J., Acevedo, N., Williams, A. R., & Caraballo, L. (2025). Ascaris Lumbricoides Cystatin Impairs IL ‐1β Maturation and CD14 Expression in Human Monocytes. Immunology. https://doi.org/10.1111/imm.70016
Vancouver
Lozano A, Zakzuk J, Acevedo N, Williams AR, Caraballo L. Ascaris Lumbricoides Cystatin Impairs IL ‐1β Maturation and CD14 Expression in Human Monocytes. Immunology. 2025. doi:10.1111/imm.70016
BibTeX
@article{Lozano2025,
author = {Lozano, Ana and Zakzuk, Josefina and Acevedo, Nathalie and Williams, Andrew R and Caraballo, Luis},
title = {Ascaris Lumbricoides Cystatin Impairs IL ‐1β Maturation and CD14 Expression in Human Monocytes},
journal = {Immunology},
year = {2025},
doi = {10.1111/imm.70016}
}
EUVIMED